SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-22-014576
Filing Date
2022-04-14
Accepted
2022-04-14 16:11:55
Documents
9
Period of Report
2022-04-14

Document Format Files

Seq Description Document Type Size
1 6-K brhc10036395_6k.htm 6-K 15021
2 EXHIBIT 99.1 brhc10036395_ex99-1.htm EX-99.1 142824
3 EXHIBIT 99.2 brhc10036395_ex99-2.htm EX-99.2 1544
4 EXHIBIT 99.3 brhc10036395_ex99-3.htm EX-99.3 19911
5 EXHIBIT 99.4 brhc10036395_ex99-4.htm EX-99.4 23052
6 image00001.jpg GRAPHIC 3123
7 image00002.jpg GRAPHIC 130075
8 image00003.jpg GRAPHIC 88491
9 image00005.jpg GRAPHIC 87840
  Complete submission text file 0001140361-22-014576.txt   630188
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39992 | Film No.: 22827375
SIC: 2836 Biological Products, (No Diagnostic Substances)